Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenazopyridine Hydrochloride for Pain in Uncomplicated UTI
NCT01064024Phase 3Completed
- Sponsor
- Amneal Pharmaceuticals, Inc.
- Start
- Dec 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in urinary tract infection (UTI) comparing Phenazopyridine Hydrochloride with Placebo (2 arms). Primary endpoint: Proportion of subjects in each treatment group who demonstrate reduction in pain or burning when passing urine at 48 hours. Started Dec 2009; status: completed.
02
Drugs
phenazopyridine
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT01064024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01064024.